Israel Pharmaceuticals & Healthcare Q4 2018
Although its attractiveness as a destination for pharmaceutical investment for has dimmed since the lowering of UScorporate rates, Israel remains the key hub for innovative medicines in the Middle East. The government's ongoing commitment toattract biotechnology companies, was underlined by a further expansion of that the country’s basket for patented drugs in2018. Additionally, Israel is emerging as a international centre for the development of effective treatments based on the specificgenetic profile of patients though digital and personalised medicine.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook